Nathan Roth

Nathan Roth serves as the Vice President of PPD at CSL Behring since August 2016, overseeing Global CMC, Global Pathogen Safety, and Plasma Product Development in Bern. Roth has extensive experience in leadership roles within R&D, having previously held positions such as Executive Director and Sr. Director at CSL Behring focused on pathogen safety and product development. Prior positions include Director roles at Grifols and Talecris Biotherapeutics, and various leadership positions at Bayer HealthCare and Aventis Behring. Nathan Roth holds a Ph.D. in Biochemistry and a B.Sc. in Microbiology, Genetics, and Molecular Biology, both from the University of Calgary.